Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Valeant Pharmaceuticals International, Inc.
Current Parent Company: Bausch Health
Penalty: $11,750,000
Year: 2013
Date: July 22, 2013
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Valeant agreed to pay over $11 million to indirect purchaser plaintiffs to settle litigation alleging that its subsidiary Biovail conspired to block the introduction of a generic version of its antidepressant Wellbutrin XL.
Level of Government: federal
Action Type: private litigation
Court: Eastern District of Pennsylvania
Civil or Criminal Case: civil
Case ID: 2:08cv2433
Case Name: Plumbers and Pipefitters Local 572 Health and Welfare Fund v. Biovail Corporation et al
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Canada
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.